1. Home
  2. INTZ vs INKT Comparison

INTZ vs INKT Comparison

Compare INTZ & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intrusion Inc.

INTZ

Intrusion Inc.

N/A

Current Price

$1.46

Market Cap

30.0M

ML Signal

N/A

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

HOLD

Current Price

$12.42

Market Cap

51.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTZ
INKT
Founded
1983
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Medicinal Chemicals and Botanical Products
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.0M
51.7M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
INTZ
INKT
Price
$1.46
$12.42
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$7.25
$35.00
AVG Volume (30 Days)
88.9K
19.7K
Earning Date
11-11-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,290,000.00
N/A
Revenue This Year
$38.09
N/A
Revenue Next Year
$27.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
33.49
N/A
52 Week Low
$0.35
$4.56
52 Week High
$7.34
$76.00

Technical Indicators

Market Signals
Indicator
INTZ
INKT
Relative Strength Index (RSI) 46.85 51.40
Support Level $1.40 $11.48
Resistance Level $1.55 $13.34
Average True Range (ATR) 0.09 0.84
MACD 0.02 0.27
Stochastic Oscillator 65.52 67.49

Price Performance

Historical Comparison
INTZ
INKT

About INTZ Intrusion Inc.

Intrusion Inc is a cybersecurity company based in Plano, Texas. The group offers customers to access its threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol (IP) addresses. The company's product consists of On-Premise Network Protection, Cyber Threat Consulting, Cloud Network Security, and Endpoint Protection. Its solutions are INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. Its end-user customers include the U.S. federal government, state and local government entities, large and diversified conglomerates, and manufacturing entities.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: